Effect of serial plasma exchange sessions with albumin replacement on ABO antibody titers

Background Donor shortage in kidney transplantation stimulates trails of live-related transplants across the ABO antibody barrier. Successful desensitization was achieved by repeated plasmapheresis with intensified immunosuppression. This study estimates the effect of serial sessions of plasma excha...

Full description

Saved in:
Bibliographic Details
Published in:The Egyptian journal of haematology : the official journal of the Egyptian Society of Haematology 2022-07, Vol.47 (3), p.217-221
Main Authors: Hassan, Mohamed, Zaki, Mahmoud, El Said, Tamer, Abdelaziz, Haitham, Al-Semrawy, Mahmoud, Elsayed, Hebatallah, Abdelmegied, Shaimaa
Format: Article
Language:English
Subjects:
Albumin
Antibodies
Plasma exchange (Therapeutics)
Transplantation of organs, tissues, etc
Viral antibodies
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Donor shortage in kidney transplantation stimulates trails of live-related transplants across the ABO antibody barrier. Successful desensitization was achieved by repeated plasmapheresis with intensified immunosuppression. This study estimates the effect of serial sessions of plasma exchange on different blood group antibody titers. Patients and methods This is a pilot study that included 25 prescribed plasma exchange treatments with albumin replacement for miscellaneous indications. Patients using plasma as a replacement during sessions, positive direct and indirect antiglobulin test and AB blood group were excluded. Blood group antibody titers were measured by the gel card method before starting plasma exchange and after each session for five sessions. Results The study included a total of 25 patients, 12 (48%) had A1 blood group, eight (32%) had blood group B, and five (20%) had blood group O. The baseline anti-(A) and anti-(B) antibody titers before plasma exchange were median (interquartile range) 128.00 (192) and 64 (64) with significant reduction after five sessions with median (interquartile range) 1 (4) and 2 (1), respectively, with P value less than 0.001. Anti-(A) and anti-(B) antibody titer percent reduction from baseline to fifth session were mean±SD=99.04 ± 0.72 and =97.93 ± 0.99%, respectively. Anti-(A) and anti-(B) antibody titers were negatively correlated with patient's age (r=0.731, P=0.005; r=0.793, P
ISSN:1110-1067
2090-9268
DOI:10.4103/ejh.ejh_28_22